In 1997, we started performing CVVH/HD in our ICU, which allowed us to improve the metabolic control of our dialysis patients. We sought to investigate the trends in mortality rates of ARF patients treated in our ICU from January 1992 to December 1998. The APACHEII score and risk of death of all patients (*n* = 10723, age 61 ± 18 years, 62% males) and of patients with ARF submitted to dialysis therapies (*n* = 256, age 61 ± 18 years, 70% males) are shown in the Table.

                               1992   1993   1994   1995   1996   1997   1998
  ---------------------------- ------ ------ ------ ------ ------ ------ ------
  Patients with dialytic ARF   34     22     27     39     38     55     41
  APACHE II score              24.5   25.9   27.6   25.9   26.6   25.4   24.7
  Risk of death (%)            45     51.2   52.4   47.1   53.3   43.7   44.7
  ICU mortality (%)            67.6   59.1   66.7   53.8   63.2   52.7   42.5
  All patients                 1343   1432   1428   1545   1691   1589   1695
  APACHE II score              13.7   13.3   14.3   14.3   14     14.3   11.3
  Risk of death (%)            19.7   18.7   19.3   19.3   19.3   20.3   14.7
  ICU mortality (%)            11.3   11.3   10.7   10     9.3    9.3    8

In 1998, for the first time, the mortality in the ARF population was lower than the expected mortality (risk of death). Comparing the 1992-1996 period with 1997-1998, there was no reduction in the expected mortality (49% versus 44%; *P* = 0.46), but there was a significant reduction in the ICU mortality (62% versus 48%; *P* = 0.04). This improvement in survival could be due to an overall improvement in our standards of care or in the dialytic therapy.
